Tag: Acute myeloid leukemia

Oncotarget
Oncotarget

Oncotarget | MK256 a Novel CDK8 Inhibitor With Potent Antitumor Activity in AML Through Downregulation of STAT Pathway

November 10, 2022
“In summary, our study shows that MK256, a potent and selective CDK8 inhibitor, is an effective negative STAT pathway regulator both in vitro and in vivo in AML.” Listen to… read more
Dr. Michael Andreeff
Oncotarget

Testimonial: Dr. Michael Andreeff

November 5, 2021
Below is a transcript of the testimonial by Dr. Michael Andreeff, from the University of Texas MD Anderson Cancer Center, about his experience publishing the paper, “Tumor Trp53 status and genotype affect the bone marrow… read more